Canada Hemodialysis and Peritoneal Dialysis Market, By Product (Hemodialysis and Peritoneal Dialysis, Device, Consumables), Modality (Conventional Long-Term, Nocturnal, Short Daily, Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis), Type (Portable Water Disinfection Systems, Central Water Disinfection Systems, Heat Disinfection Systems, Chemical Disinfection Systems, Accessories), End User (Dialysis Centers, Hospitals, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail sales) – Industry Trends and Forecast to 2030.
Canada Hemodialysis and Peritoneal Dialysis Market Analysis and Size
According to the NCBI, 10.8% of U.S. residents are dialyzed at home as of 2017, representing a 30% increase in home dialysis over the previous decade. In 2019, the Advancing Kidney Health Initiative proposed increasing the number of patients with renal failure who receive hemodialysis or peritoneal dialysis at home, driving market growth in the forecast period of 2023-2030.
Data Bridge Market Research analyses that the hemodialysis and peritoneal dialysis market which is USD 970.48 million in 2022, is expected to reach USD 1523.62 million by 2030, at a CAGR of 5.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Canada Hemodialysis and Peritoneal Dialysis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Hemodialysis and Peritoneal Dialysis, Device, Consumables), Modality (Conventional Long-Term, Nocturnal, Short Daily, Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis), Type (Portable Water Disinfection Systems, Central Water Disinfection Systems, Heat Disinfection Systems, Chemical Disinfection Systems, Accessories), End User (Dialysis Centers, Hospitals, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail sales)
|
|
Market Players Covered
|
Medtronic (Ireland), Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Baxter International, Inc. (U.S.), B. Braun SE (Germany), Nipro (Japan), Cantel Medical Corporation (U.S.), NIKKISO CO., LTD (Japan), Diaverum Healthcare Partners (Germany), Asahi Kasei Corporation (Japan), Rockwell Medical, Inc. (U.S.), BD (U.S.), Dialife Group (Switzerland) and Isopure Corp. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Hemodialysis is performed using a machine. Peritoneal dialysis filters your blood through your abdomen's lining, known as the peritoneal membrane. Another form of dialysis that eliminates waste from the blood when your kidneys are not working properly is peritoneal dialysis. Hemodialysis and peritoneal dialysis differ most in that hemodialysis uses a machine that simulates a kidney to filter blood, whereas peritoneal dialysis does not.
Canada Hemodialysis and Peritoneal Dialysis Market Dynamics
Drivers
- Increasing prevalence of AKIs
The increasing prevalence of AKIs is expected to drive the demand for hemodialysis and peritoneal dialysis. For instance, the National Kidney Foundation, Inc. projected that more than one in seven adults are affected by kidney disease. The graph below depicts the percentage of U.S. adults aged 18 and up, by gender, who have Chronic Kidney Disease (CKD). According to the CDC, more than 37 million people are thought to have CKD. Additionally, the same source states that CKD is more prevalent in those over 65 and can result in dialysis.
- Rise in demand for dialysis
The demand for dialysis has increased in recent years. According to the National Kidney Foundation, 785,883 U.S. residents experienced kidney failure in 2018, with 554,038 receiving dialysis. Similarly, according to FDA data, approximately 10,000 children in the United States develop acute AKI. These children have a survival rate of around 38% to 43%. The mortality rate for neonates with AKI is approximately 60%. Fluid overload is common in critically ill neonates and children, particularly following procedures such as cardiac surgery. These factors are likely to fuel demand for neonatal hemodialysis, propelling market growth.
Opportunities
- Rising prevalence of chronic kidney disease
The rising prevalence of chronic kidney disease and Medicare spending on healthcare are driving the country's market growth. According to the National Kidney Foundation, over 500,000 patients received dialysis in 2019 and over 200,000 people received kidney transplants. Furthermore, the cost of a billion dollars in 2017 was borne by the people. The e-mail system is a waste of time, the e-mail system, the e-mail system of the e-mail system of the of the (ESKD).
Restraints/Challenges
- Risks associated with dialysis
Hemodialysis differs from PD in that it frequently necessitates patientsl three times per week for sessions that last around four hours. Some patients, though, might be able to perform hemodialysis at home.
This hemodialysis and peritoneal dialysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemodialysis and peritoneal dialysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Hemodialysis and Peritoneal Dialysis Market
The COVID-19 pandemic significantly impacted the global hemodialysis and peritoneal dialysis market. There was an unexpected increase in demand for dialysis devices and consumables due to the high hospitalization rates caused by the pandemic. According to CDC statistics from 2021, CKD affected an estimated 37 million Americans, or one in every seven adults. This was primarily due to the increased prevalence of comorbid conditions like CKD, diabetes, and hypertension. Furthermore, the pandemic caused significant disruptions in the supply chain, making it difficult for manufacturers to keep up with demand. Furthermore, post-COVID-19 market expansion is anticipated to be aided by growing geriatric medical demands, rising demand for novel products and therapies, and developments in medical technology.
Recent Developments
- In 2019, Baxter and Ayogo collaborated to launch the CKD&Me Patient Empowering Digital Education Tool. This tool helped nephrologists learn about hemodialysis and other kidney-related issues. This tool's release aided the company in strengthening its renal care platform.
- In 2020, Fresenius Medical Care AG & Co. KGaA expanded its home care dialysis products in Europe, the Middle East, and Africa. Home dialysis products offer patients low-cost treatment in the comfort of their own homes. This expansion helped the company to penetrate in parent market of home dialysis.
- In 2019, Fresenius Medical Care AG & Co. KGaA expanded its clinical research activities in North America to accelerate the clinical development of dialysis products, among other things. This growth enabled the company to create more innovative dialysis products.
Canada Hemodialysis and Peritoneal Dialysis Market Scope
The hemodialysis and peritoneal dialysis market is segmented on the basis of product, modality, type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Hemodialysis and Peritoneal Dialysis
- Device
- Consumables
Modality
- Conventional Long-Term
- Nocturnal
- Short Daily
- Continuous Ambulatory Peritoneal Dialysis
- Automated Peritoneal Dialysis
Type
- Portable Water Disinfection Systems
- Central Water Disinfection Systems
- Heat Disinfection Systems
- Chemical Disinfection Systems
- Accessories
End User
- Dialysis Centers
- Hospitals
- Home Care Settings
- Others
Distribution Channel
- Direct Tender
- Retail sales
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The hemodialysis and peritoneal dialysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hemodialysis and peritoneal dialysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hemodialysis and peritoneal dialysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Hemodialysis and Peritoneal Dialysis Market Share Analysis
The hemodialysis and peritoneal dialysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hemodialysis and peritoneal dialysis market.
Some of the major players operating in the hemodialysis and peritoneal dialysis market are:
- Fresenius Medical Care AG & Co. KGaA (Germany)
- DaVita Healthcare Partners, Inc. (U.S.)
- Baxter International, Inc. (U.S.)
- B. Braun SE (Germany)
- Nipro (Japan)
- Cantel Medical Corporation (U.S.)
- NIKKISO CO., LTD (Japan)
- Diaverum Healthcare Partners (Germany)
- Asahi Kasei Corporation (Japan)
- Medtronic (Ireland)
- Rockwell Medical, Inc. (U.S.)
- BD (U.S.)
- Dialife Group (Switzerland)
- Isopure Corp. (U.S.)
SKU-